Capabilities Overview

Advance your therapy with a CDMO built to support every stage of development. Kincellis combines deep cell therapy expertise, emerging mRNA capabilities, comprehensive analytical services, and flexible GMP manufacturing across three U.S. facilities.

Download our sell sheet to explore how our collaborative, quality-first approach can help streamline CMC development, reduce program risk, and establish a reliable path from IND through commercialization.